<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Septic arthritis in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Septic arthritis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Septic arthritis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Don L Goldenberg, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sandra Nelson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Septic arthritis is synonymous with an infection in a joint. Septic arthritis is usually caused by bacteria but can also be caused by other microorganisms. Septic arthritis due to bacterial infection is often a destructive form of acute arthritis [<a href="#rid1">1</a>].</p><p>The epidemiology, microbiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of septic arthritis of native joints due to typical bacteria are reviewed here. An overview of monoarthritis in adults is presented separately. (See  <a class="medical medical_review" href="/d/html/1820.html" rel="external">"Monoarthritis in adults: Etiology and evaluation"</a>.)</p><p>Issues related to prosthetic joint infection are discussed separately. (See  <a class="medical medical_review" href="/d/html/7664.html" rel="external">"Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7665.html" rel="external">"Prosthetic joint infection: Treatment"</a>.)</p><p>Issues related to septic arthritis in children are discussed separately. (See  <a class="medical medical_review" href="/d/html/6030.html" rel="external">"Bacterial arthritis: Clinical features and diagnosis in infants and children"</a> and  <a class="medical medical_review" href="/d/html/6033.html" rel="external">"Bacterial arthritis: Treatment and outcome in infants and children"</a>.)</p><p>Issues related to gonococcal arthritis, lyme arthritis, and viral causes of arthritis are discussed separately. (See  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a> and  <a class="medical medical_review" href="/d/html/7894.html" rel="external">"Musculoskeletal manifestations of Lyme disease"</a> and  <a class="medical medical_review" href="/d/html/5614.html" rel="external">"Viral arthritis: Causes and approach to evaluation and management"</a>.)</p><p class="headingAnchor" id="H1223252882"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In the United States in 2012, septic arthritis was responsible for 16,000 emergency department visits [<a href="#rid2">2</a>].</p><p>Predisposing factors include [<a href="#rid3">3-8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Advance age</p><p class="bulletIndent1"><span class="glyph">●</span>Pre-existing joint disease</p><p class="bulletIndent1"><span class="glyph">●</span>Recent joint surgery or injection</p><p class="bulletIndent1"><span class="glyph">●</span>Skin or soft tissue infection</p><p class="bulletIndent1"><span class="glyph">●</span>Injection drug use (IDU)</p><p class="bulletIndent1"><span class="glyph">●</span>Indwelling catheters</p><p class="bulletIndent1"><span class="glyph">●</span>Immunosuppression (including diabetes)</p><p></p><p>Most commonly, septic arthritis arises via hematogenous seeding. Bacteremia is more likely to localize in a joint with pre-existing arthritis (such as rheumatoid arthritis, osteoarthritis, gout, pseudogout, Charcot arthropathy), particularly if associated with synovitis [<a href="#rid9">9-11</a>]. Patients with rheumatoid arthritis, may have additional predisposing factors, such as intra-articular steroid injections and use of immunosuppressive medications [<a href="#rid12">12-15</a>].</p><p>In one series including more than 500 adult cases of native joint septic arthritis in New Zealand between 2009 and 2014, large joint septic arthritis (involving the knee, shoulder, hip, ankle, wrist, or elbow) occurred more frequently than small joint septic arthritis (involving the finger, toe, acromioclavicular, or sternoclavicular joints; incidence 13 versus 8 per 100,000 person-years) [<a href="#rid16">16</a>]. </p><p>IDU has become an increasingly important risk factor for septic arthritis in the United States in the context of the opioid epidemic; consequently, septic arthritis has been observed more frequently in younger patients with no other comorbidities [<a href="#rid17">17</a>]. In one study in Boston, IDU was a factor in 20 percent of septic arthritis cases between 2009 and 2018 (compared with 10 percent between 1990 and 2008) [<a href="#rid18">18</a>]. Most of these infections were due to <em>Staphylococcus aureus</em>; one-third were methicillin resistant. There was frequent involvement of the sacroiliac, acromioclavicular, and facet joints. </p><p class="headingAnchor" id="H4533994"><span class="h1">MECHANISM OF INFECTION</span><span class="headingEndMark"> — </span>Septic arthritis develops as a result of hematogenous seeding, direct inoculation of bacteria into the joint, or contiguous spread from an adjacent soft tissue or bone infection [<a href="#rid10">10,11,19</a>].</p><p>Most commonly, septic arthritis arises via hematogenous seeding of the synovial membrane (which has no limiting basement membrane, thus allowing organisms to enter the joint space). Septic arthritis due to hematogenous seeding is most commonly caused by organisms with propensity to adhere to the synovial tissues (such as <em>S. aureus</em>) [<a href="#rid20">20</a>]. Hematogenous seeding most commonly involves large joints [<a href="#rid16">16</a>].</p><p>Bacterial arthritis can also occur via direct inoculation of bacteria into the joint; mechanisms include bite wounds, trauma, arthroscopy or other surgery, and intra-articular injection [<a href="#rid21">21,22</a>]. Septic arthritis following an intra-articular injection is uncommon; rarely it occurs in clusters due to unsafe injection practices [<a href="#rid21">21,23</a>].</p><p>Rarely, septic arthritis develops via extension of infection into the joint space from adjacent tissues. In the setting of long-bone osteomyelitis, infection within the metaphysis can break through the bone cortex, leading to discharge of pus into the joint. This occurs in joints in which the metaphysis is within the capsular reflection (eg, knees, hip, shoulder, and elbows). (See  <a class="medical medical_review" href="/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis", section on 'Hematogenous osteomyelitis'</a>.) </p><p>Other examples include complications of subclavian vein and femoral catheterization (resulting in septic arthritis of the sternoclavicular and hip joints, respectively), and ruptured diverticulitis, resulting in dissection of infection via the retroperitoneal space into the posterior thigh and hip joint [<a href="#rid24">24-26</a>].</p><p class="headingAnchor" id="H8"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Numerous pathogens are capable of causing septic arthritis  (<a class="graphic graphic_table graphicRef57688" href="/d/graphic/57688.html" rel="external">table 1</a>). The microbiology of septic arthritis depends in part on the mechanism of infection and relevant epidemiologic exposures. (See <a class="local">'Epidemiology'</a> above.)</p><p>Septic arthritis is usually monomicrobial. <em>S. aureus</em> (including methicillin-resistant <em>S. aureus</em>) is the most common cause of septic arthritis in adults [<a href="#rid4">4,11,27</a>]. Other gram-positive organisms such as streptococci are also important potential causes of septic arthritis [<a href="#rid28">28</a>]. <em>Streptococcus pneumoniae</em> is responsible for a small percentage of cases of septic arthritis in adults [<a href="#rid29">29</a>].</p><p>Septic arthritis due to gram-negative bacilli generally occurs in older adults, in patients with underlying immunosuppression, or intravenous drug users; it may also occur as a complication of trauma. Patients with underlying immunosuppression and intravenous drug users are at risk for infection due to <em>Pseudomonas </em>[<a href="#rid30">30</a>]. </p><p>Polymicrobial septic arthritis is uncommon; it may occur in the setting of penetrating trauma involving the joint space or via hematogenous seeding in patients with polymicrobial bacteremia. Small joint septic arthritis is more likely to be polymicrobial and caused by streptococci, <em>Eikenella</em>, or anaerobic bacteria [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H9"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2766713848"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span>Patients with septic arthritis usually present acutely with a single swollen and painful joint (ie, monoarticular arthritis) [<a href="#rid31">31</a>]. Joint pain, swelling, warmth, and restricted movement occur in 80 percent of patients with septic arthritis [<a href="#rid3">3</a>]. Most patients with septic arthritis are febrile; however, older patients with septic arthritis may be afebrile [<a href="#rid3">3</a>].</p><p>The knee is involved in more than 50 percent of cases; wrists, ankles, and hips are also affected commonly [<a href="#rid10">10</a>]. Infection of the symphysis pubis is uncommon [<a href="#rid32">32</a>]. Involvement of axial joints (such as the sternoclavicular, acromioclavicular, or sternomanubrial joint) may occur in people who inject drugs (PWID) [<a href="#rid18">18,33</a>]. (See  <a class="medical medical_review" href="/d/html/14007.html" rel="external">"Pelvic osteomyelitis and other infections of the bony pelvis in adults"</a>.)</p><p>Oligoarticular or polyarticular infection (usually two or three joints) occurs in approximately 20 percent of patients with septic arthritis. Polyarticular septic arthritis is most likely to occur in patients with sepsis and underlying rheumatoid arthritis or other systemic connective tissue disease [<a href="#rid34">34</a>].</p><p>Septic arthritis may be a presenting manifestation of infective endocarditis; this occurs most commonly among PWID [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.)</p><p>In septic arthritis that occurs as a result of hematogenous seeding, blood cultures are positive in approximately 50 percent of cases [<a href="#rid11">11</a>]. Laboratory findings such as elevated white blood cell count, erythrocyte sedimentation rate, and C-reactive protein are common but nonspecific [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H2288307224"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The physical examination should include thorough evaluation of all joints for erythema, swelling, warmth, and tenderness [<a href="#rid3">3</a>]. Infected joints are characteristically painful and usually demonstrate an effusion, both of which are associated with limited active and passive range of motion. External findings such as swelling, erythema, and warmth may be less prominent in the setting of septic arthritis involving the hip, shoulder or spine joints. In addition, physical exam findings may be less prominent in patients who are older adults and/or immunocompromised. </p><p class="headingAnchor" id="H10"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3235027573"><span class="h2">General approach</span><span class="headingEndMark"> — </span>The diagnosis of septic arthritis should be suspected in patients with acute onset of at least one swollen, painful joint, with or without relevant risk factors (including bacteremia, pre-existing joint disease, and immunosuppression).</p><p>The diagnosis of septic arthritis is made based on synovial fluid analysis and culture  (<a class="graphic graphic_algorithm graphicRef111452" href="/d/graphic/111452.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef76506" data-inline-graphics="76506" href="/d/graphic/76506.html" rel="external">table 2</a>). Septic arthritis may be definitively established in the setting of positive synovial fluid Gram stain and/or culture [<a href="#rid3">3</a>]. In patients with purulent synovial fluid (leukocyte count &gt;20,000 cells/microL, mostly neutrophils) but negative synovial fluid cultures, a presumptive diagnosis of septic arthritis may be made. (See <a class="local">'Interpreting synovial fluid test results'</a> below and <a class="local">'Differential diagnosis'</a> below.) </p><p>In addition, blood cultures (two sets) and, when indicated, radiographs, ultrasound, or imaging studies of the involved joint should be obtained.</p><p>In the setting of septic arthritis due to organisms that commonly cause endocarditis (such as <em>S. aureus</em>, streptococci, or enterococci) with no clear predisposing cause, evaluation for endocarditis should be pursued. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.)</p><p class="headingAnchor" id="H2792003158"><span class="h2">Obtaining clinical specimens</span><span class="headingEndMark"> — </span>Collection of synovial fluid and blood cultures should be performed prior to administration of antibiotics. If synovial fluid cannot be obtained with closed needle aspiration, the joint should be aspirated under radiographic guidance. Certain joints (such as the hip or sacroiliac joint) may require surgical arthrotomy, which may be accompanied by irrigation and drainage. The only definitive way to diagnose a septic joint is via synovial fluid culture.</p><p>Synovial fluid should be sent for Gram stain, bacterial culture, white blood cell count with differential, and assessment for crystals (monosodium urate and calcium pyrophosphate crystal deposition crystals) with a polarizing microscope. </p><p>Synovial fluid may be sent for culture in a sterile tube (ideally with an anticoagulant such as ethylenediaminetetraacetic acid [EDTA] to guard against clotting) and/or in blood culture bottles (aerobic and anaerobic) [<a href="#rid37">37-40</a>]. If blood culture bottles are used, synovial fluid also should also be sent in a sterile container to allow Gram stain microscopy. Use of blood culture bottles may increase the likelihood of recovering nonpathogenic skin contaminants; in such cases, culture results should be interpreted in the context of the Gram stain result. The use of blood culture bottles has no significant advantage when common causes of septic arthritis such as <em>S. aureus</em> is suspected [<a href="#rid41">41</a>] but may have advantages in detecting unusual organisms such as <em>Kingella</em> and <em>Brucella</em> [<a href="#rid42">42</a>]. <em>Kingella kingae</em> occurs more commonly in children than adults. (See  <a class="medical medical_review" href="/d/html/6030.html" rel="external">"Bacterial arthritis: Clinical features and diagnosis in infants and children"</a>.) </p><p>Nucleic acid amplification tests such as polymerase chain reaction and other advanced diagnostic methods such as MALDI-TOF mass spectometry may be useful when routine cultures are negative and the suspicion for infection remains high; in infections due to <em>N. gonorrhoeae</em> cases (see  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a>); or cases in which prior treatment with antibiotics is suspected as having led to a spuriously negative routine culture. When positive, such test results need to be interpreted carefully and correlated with Gram stains and clinical and epidemiologic findings, because extremely small amounts of contaminating bacterial material can lead to a false-positive result [<a href="#rid43">43</a>].</p><p>Measurement of procalcitonin levels (in the serum and/or synovial fluid) has been proposed as tools for diagnosis of septic arthritis, particularly when synovial fluid is difficult to obtain or in patients with coexisting inflammatory arthritis. </p><p>The sensitivity of serum procalcitonin level is relatively low (pooled sensitivity in 10 studies 0.54 [95% CI 0.41-0.66]), as is the negative likelihood ratio (0.49 [95% CI 0.38-0.62]); thus, such a test cannot be used to rule out septic arthritis. The specificity of serum procalcitonin is higher (pooled sensitivity in one meta-analysis 0.95 [95% CI 0.87-0.96]); thus a positive test may be useful occasionally in deciding if a difficult-to-access joint such as the hip or sacroiliac joint should be aspirated [<a href="#rid44">44,45</a>]. There are limited data to suggest that synovial fluid procalcitonin levels may be more predictive of septic arthritis than blood levels [<a href="#rid46">46</a>]; however, such testing is not needed if a culture is obtained at the time of joint aspiration. </p><p>Other synovial fluid assays (such as synovial fluid lactate, glucose, C-reactive protein, polymerase chain reaction, or immunoassays) are not useful for diagnosis of septic arthritis [<a href="#rid47">47-49</a>].</p><p>Synovial biopsy is rarely necessary, but may be indicated if there is evidence of concurrent contiguous osteomyelitis, in rare cases in which joint aspiration fails to provide a satisfactory sample for diagnostic testing, or when infection or coinfection with <em>M. tuberculosis</em> or other slow growing pathogens is a possibility. </p><p class="headingAnchor" id="H1926610274"><span class="h2">Interpreting synovial fluid test results</span><span class="headingEndMark"> — </span>In the setting of septic arthritis, synovial fluid analysis typically demonstrates the following  (<a class="graphic graphic_table graphicRef76506" href="/d/graphic/76506.html" rel="external">table 2</a> and <a class="graphic graphic_algorithm graphicRef111452" href="/d/graphic/111452.html" rel="external">algorithm 1</a>) [<a href="#rid11">11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Leukocyte count of 50,000 to 150,000 cells/microL (mostly neutrophils) [<a href="#rid37">37</a>]. The likelihood of septic arthritis increases as the synovial fluid leukocyte count increases [<a href="#rid4">4,16</a>]. High synovial fluid white blood cell counts can also occur in other conditions, so it is important to interpret the results of synovial fluid testing in the overall clinical context. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gram stain is positive in some cases; the sensitivity is 30 to 50 percent [<a href="#rid3">3</a>]. False-positive results may reflect precipitated crystal violet and mucin in the synovial fluid, which can mimic the appearance of gram-positive cocci. False-negative results may occur if crystals are present or if clotting occurs [<a href="#rid38">38,50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Synovial fluid culture is positive in the more than 60 percent of patients with nongonococcal bacterial arthritis [<a href="#rid51">51</a>]. Negative synovial fluid cultures may occur in the setting of recent antimicrobial therapy or infection with a fastidious organism.</p><p></p><p class="bulletIndent1">In one retrospective study including 383 patients with suspected septic arthritis (of whom 82 patients received antibiotics prior to the initial synovial fluid analysis), a leukocyte count between 16,000 and 33,000 cells/microL with &gt;90 percent neutrophils was strongly suggestive of septic arthritis [<a href="#rid52">52</a>].</p><p></p><p class="headingAnchor" id="H2800939787"><span class="h2">Radiographic imaging</span><span class="headingEndMark"> — </span>Radiographs of the involved joint should be obtained for evaluation of concurrent bone and joint disease; in addition, baseline radiography is often useful to guide subsequent management decisions. For joints that are difficult to examine (such as the hip or sacroiliac joint), computed tomography or magnetic resonance imaging are useful for detection of effusion. Nuclear imaging is not warranted for suspected septic arthritis. There are insufficient data to support a role for fluorodeoxyglucose-positron emission tomography scans in diagnosis of septic arthritis [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/d/html/6921.html" rel="external">"Imaging techniques for evaluation of the painful joint"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of septic arthritis includes infectious as well as noninfectious illnesses  (<a class="graphic graphic_table graphicRef62597" data-inline-graphics="62597" href="/d/graphic/62597.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef74266" href="/d/graphic/74266.html" rel="external">table 4</a>) [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/d/html/1820.html" rel="external">"Monoarthritis in adults: Etiology and evaluation"</a>.)</p><p>Other causes of infection include septic bursitis and alternate infectious causes of arthritis:</p><p class="bulletIndent1"><span class="glyph">●</span>Septic bursitis – Septic bursitis refers to inflammation of the bursa due to infection; the mechanisms for development of septic bursitis are the same as the mechanisms for development of septic arthritis. The diagnosis of septic bursitis is confirmed by culture of fluid from the affected bursa. (See  <a class="medical medical_review" href="/d/html/7650.html" rel="external">"Septic bursitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gonococcal arthritis – Gonococcal arthritis typically presents acutely in sexually active individuals with fever, chills, skin lesions, polyarthralgias, and tenosynovitis, evolving into a persistent monoarthritis or oligoarthritis. The diagnosis of disseminated gonococcal infection is made by identification of <em>Neisseria gonorrhoeae</em> (either through molecular testing or culture) via nucleic acid amplification testing or culture of a specimen of blood, synovial fluid or tissue, skin lesion, or other nonmucosal site. Culture requires processing on chocolate agar plates, Thayer-Martin medium, or other selective gonococcal medium; the organism cannot be cultured on routine culture media. (See  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lyme disease – Lyme disease should be suspected in patients with an acute monoarthritis in the setting of epidemiologic exposure in an endemic area; erythema migrans rash, fever, and migratory arthralgias may occur weeks or months prior. The diagnosis is established via serologic testing. (See  <a class="medical medical_review" href="/d/html/7894.html" rel="external">"Musculoskeletal manifestations of Lyme disease", section on 'Diagnosis of Lyme arthritis'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculous arthritis – Tuberculous arthritis should be suspected in patients with indolent presentation of persistent culture-negative oligoarthritis or monoarthritis, in the setting of relevant epidemiologic exposure. The sensitivity of synovial fluid Ziehl-Neelsen stain for detection of acid-fast bacilli is low; the diagnosis is established via synovial membrane histopathology and culture. (See  <a class="medical medical_review" href="/d/html/7658.html" rel="external">"Bone and joint tuberculosis", section on 'Arthritis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral causes of arthritis – Viral causes of arthritis typically present with polyarthritis; they include chikungunya, dengue fever, Zika virus, parvovirus, Ross River virus, Barmah Forest virus, and rubella. A number of other viruses including enterovirus, adenovirus, and alphaviruses may also cause arthritis. (See  <a class="medical medical_review" href="/d/html/5614.html" rel="external">"Viral arthritis: Causes and approach to evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fungal arthritis – Fungal arthritis should be suspected in patients with indolent presentation of persistent culture-negative oligoarthritis or monoarthritis, in the setting of relevant epidemiologic exposure, penetrating trauma, or immunosuppression. Fungal causes of arthritis include sporotrichosis, coccidioidomycosis, candidiasis, and others [<a href="#rid55">55</a>]. The diagnosis is established via fungal stain and culture of synovial fluid or via synovial membrane histopathology and culture.</p><p></p><p>Noninfectious causes of arthritis include trauma and inflammatory arthritis:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute traumatic arthritis – Acute traumatic arthritis usually causes bloody synovial fluid and is generally associated with a history of significant trauma to the joint. (See  <a class="medical medical_review" href="/d/html/5605.html" rel="external">"Overview of hemarthrosis", section on 'Traumatic'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Crystal-induced arthritis (gout or pseudogout) – Manifestations of crystal-induced arthritis include monoarthritis and leukocytosis. Clues suggestive of gout include involvement of the first metatarsophalangeal joint, prior self-limited attacks of arthritis, and presence of tophi. The diagnosis of crystal-induced arthritis can be established by synovial fluid analysis demonstrating monosodium urate crystals of gout or calcium pyrophosphate dihydrate crystals of pseudogout. </p><p></p><p class="bulletIndent1">Concurrent crystal-induced and septic arthritis can occur [<a href="#rid56">56</a>]. In patients with concurrent gout and septic arthritis, the synovial fluid Gram stain may be negative; thus, cultures should be performed if concurrent infection is suspected [<a href="#rid50">50</a>]. The synovial fluid leukocyte count is often above 50,000<sup>/</sup>mm<sup>3</sup> in gout and calcium pyrophosphate crystal deposition disease; therefore, this finding cannot be used to distinguish from septic arthritis [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/1667.html" rel="external">"Clinical manifestations and diagnosis of gout"</a> and  <a class="medical medical_review" href="/d/html/1668.html" rel="external">"Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition (CPPD) disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reactive arthritis or spondyloarthritis – Chronic inflammatory joint disease can present with a new swollen joint, simulating septic arthritis; this is especially common in the seronegative spondyloarthropathies such as reactive arthritis. Most patients with reactive arthritis have recent genitourinary or gastrointestinal signs or symptoms, conjunctivitis, or skin or mucus membrane lesions. Occasionally, patients with ankylosing spondylitis present with acute-onset hip arthritis that mimics septic arthritis. (See  <a class="medical medical_review" href="/d/html/7794.html" rel="external">"Reactive arthritis"</a> and  <a class="medical medical_review" href="/d/html/7786.html" rel="external">"Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avascular necrosis – Avascular necrosis refers to damage of the bone vasculature leading to mechanical bone failure; it can occur in the context of a number of conditions. It usually occurs in the anterolateral femoral head, although it may also affect the femoral condyles, humeral heads, proximal tibia, vertebrae, and small bones of the hand and foot. It typically presents with localized pain. The diagnosis is established via radiographic imaging. (See  <a class="medical medical_review" href="/d/html/122049.html" rel="external">"Clinical manifestations and diagnosis of osteonecrosis (avascular necrosis of bone)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rheumatoid arthritis – Rheumatoid arthritis (RA) is typically a symmetric, chronic polyarthritis; however, acute or subacute exacerbation of one or a few joints can occur. The diagnosis may be difficult to establish because the clinical findings may be atypical; many patients with RA and superimposed septic arthritis present indolently (rather than acutely), often with little fever or leukocytosis. Conversely, RA itself may present with a "pseudoseptic arthritis" picture, including an explosive acute synovitis with a marked synovial fluid leukocytosis. The diagnosis of RA is established via clinical criteria summarized separately. (See  <a class="medical medical_review" href="/d/html/7504.html" rel="external">"Diagnosis and differential diagnosis of rheumatoid arthritis"</a>.)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Management of acute bacterial arthritis consists of joint drainage and antibiotic therapy [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H2651385965"><span class="h2">Joint drainage</span><span class="headingEndMark"> — </span>In general, patients with septic arthritis warrant joint drainage, since this condition represents a closed abscess. Approaches to joint drainage for management of septic arthritis in adults include needle aspiration, arthroscopic drainage, or arthrotomy (open surgical drainage). The choice of approach depends on clinical factors including the joint affected and the duration of infection.</p><p>For septic arthritis of the knee, elbow, ankle, or wrist, the joint may be drained via needle aspiration or arthroscopy. For septic arthritis of the hip, shoulder, or difficult-to-access joint (such as the sternoclavicular joint), the joint should be drained by arthroscopy. In any joint, arthroscopy may facilitate more thorough irrigation [<a href="#rid59">59-62</a>]. In one retrospective series including 72 cases of septic knee arthritis and 25 cases of septic hip arthritis, aspiration and surgical drainage were equally effective; aspiration was associated with a shorter hospital stay (21 versus 33 days) [<a href="#rid63">63</a>].</p><p>Surgical drainage is warranted in the following circumstances [<a href="#rid10">10,11,64-66</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Adequate drainage cannot be achieved by needle aspiration or arthroscopy</p><p class="bulletIndent1"><span class="glyph">●</span>Suspicion for penetrating trauma with a residual foreign body</p><p class="bulletIndent1"><span class="glyph">●</span>Joint effusion persists after seven days of serial aspiration</p><p></p><p>Patients with severe infection may require repeated aspirations or arthroscopic irrigations, and in some cases, synovectomy [<a href="#rid8">8</a>]. Serial synovial fluid analyses should be performed; as infection is treated, these findings should demonstrate sterilization of the fluid and decreasing total white blood cell count. Adequacy of drainage may also be assessed clinically (based on improvement in fever curve, white blood cell count, joint swelling, and pain).</p><p class="headingAnchor" id="H3385742530"><span class="h2">Antibiotic therapy</span></p><p class="headingAnchor" id="H18"><span class="h3">Initial approach</span><span class="headingEndMark"> — </span>The initial choice of empiric antimicrobial therapy should cover the most likely pathogens. The approach below is supported by case series [<a href="#rid4">4</a>]; there are no randomized trials.</p><p class="bulletIndent1"><span class="glyph">●</span>If the initial Gram stain of synovial fluid demonstrates gram-positive cocci, empiric treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>  (<a class="graphic graphic_table graphicRef128911" href="/d/graphic/128911.html" rel="external">table 5</a>) should be administered  (<a class="graphic graphic_algorithm graphicRef134805" data-inline-graphics="134805" href="/d/graphic/134805.html" rel="external">algorithm 2</a>) [<a href="#rid67">67</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with septic arthritis due to methicillin-susceptible <em>S. aureus</em> should be treated with a beta-lactam agent such as <a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a> (2 g intravenously [IV] every eight hours), <a class="drug drug_general" data-topicid="9674" href="/d/drug information/9674.html" rel="external">nafcillin</a> or <a class="drug drug_general" data-topicid="9724" href="/d/drug information/9724.html" rel="external">oxacillin</a> (2 g IV every four hours), or flucloxacillin (2 g IV every six hours). Patients who are allergic to penicillin can be treated with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with septic arthritis due to methicillin-resistant <em>S. aureus</em> should be treated with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>; if this is not feasible due to allergy or drug intolerance, reasonable alternative agents include <a class="drug drug_general" data-topicid="9304" href="/d/drug information/9304.html" rel="external">daptomycin</a> (6 mg/kg/day IV), <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a> (600 mg orally or IV twice daily), or <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> (600 mg orally or IV three times daily) [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the initial Gram stain of synovial fluid demonstrates gram-negative bacilli, treatment should be guided by risk for <em>Pseudomonas</em> infection  (<a class="graphic graphic_algorithm graphicRef134805" href="/d/graphic/134805.html" rel="external">algorithm 2</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with risk for <em>Pseudomonas</em> infection (eg, immunosuppressed patients and people who inject drugs [PWID]) warrant empiric coverage for <em>Pseudomonas</em> infection. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients who have sepsis or septic shock, have neutropenia and bacteremia, have severe burns, or are in a setting where the incidence of resistance to the chosen antibiotic class is high (eg, &gt;10 to 15 percent), we administer empiric therapy with a combination of two antipseudomonal agents from different antibiotic classes (eg, a beta-lactam with an aminoglycoside or a fluoroquinolone)  (<a class="graphic graphic_table graphicRef91115" href="/d/graphic/91115.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/d/html/3135.html" rel="external">"Principles of antimicrobial therapy of Pseudomonas aeruginosa infections", section on 'Role of combination antimicrobial therapy'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients without any of these additional risk factors for mortality or resistant organisms, we administer empiric treatment with a single antipseudomonal agent (eg, <a class="drug drug_general" data-topicid="9226" href="/d/drug information/9226.html" rel="external">ceftazidime</a> 2 g IV every eight hours or <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a> 2 g IV every 8 to 12 hours).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with no risk factors for <em>Pseudomonas</em> infection warrant treatment with a third-generation cephalosporin (eg, <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> 2 g IV once daily or <a class="drug drug_general" data-topicid="9221" href="/d/drug information/9221.html" rel="external">cefotaxime</a> 2 g IV every eight hours). </p><p></p><p class="bulletIndent1">Empiric antimicrobial therapy should be tailored to antimicrobial susceptibility data when available. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the initial Gram stain of synovial fluid is negative but synovial fluid cell count is consistent with septic arthritis, the approach depends on individual clinical circumstances  (<a class="graphic graphic_algorithm graphicRef134806" data-inline-graphics="134806" href="/d/graphic/134806.html" rel="external">algorithm 3</a>) [<a href="#rid30">30</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For immunocompetent patients without confounding factors (such as trauma), we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with traumatic bacterial arthritis, we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> plus a third-generation cephalosporin (<a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> or <a class="drug drug_general" data-topicid="9221" href="/d/drug information/9221.html" rel="external">cefotaxime</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For immunocompromised patients and PWID, we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> plus a cephalosporin with activity against <em>Pseudomonas</em> (<a class="drug drug_general" data-topicid="9226" href="/d/drug information/9226.html" rel="external">ceftazidime</a> or <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a>).</p><p></p><p>For patients with septic arthritis associated with an animal bite, the approach to antibiotic selection is discussed separately. (See  <a class="medical medical_review" href="/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management", section on 'Management'</a>.)</p><p>The initial antibiotic regimen should be tailored to culture and susceptibility results when available. As an example, <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> should be discontinued in patients with staphylococcal or streptococcal infections that are susceptible to beta-lactam therapy.</p><p>In some circumstances, parenteral therapy may be switched to oral therapy following debridement and finalization of microbiology data [<a href="#rid68">68</a>]. Considerations include pathogen susceptibility to an oral antimicrobial agent with good bioavailability and substantial barrier to use of outpatient parenteral therapy. We do not use oral therapy for treatment of septic arthritis in the context of <em>S. aureus</em> bacteremia, poor compliance, or gastrointestinal conditions that could interfere with absorption [<a href="#rid69">69</a>]. </p><p>There is no role for intra-articular antibiotics, since systemic antibiotic therapy produces adequate drug levels in joint fluid. Furthermore, direct instillation of antibiotics into a joint may induce an inflammatory response and carries a risk of iatrogenic complications such as secondary infection [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H20"><span class="h3">Duration</span><span class="headingEndMark"> — </span>The optimal duration of antimicrobial therapy for treatment of septic arthritis is uncertain. The approach below is supported by case series [<a href="#rid4">4</a>]. </p><p>For patients with septic arthritis due to <em>S. aureus </em>in the setting of concomitant bacteremia (but no evidence of endocarditis), we administer parenteral therapy for four weeks.</p><p>For patients with septic arthritis due to <em>S. aureus </em>in the absence of concomitant bacteremia or signs of endocarditis, we administer parenteral antibiotics for at least 14 days, followed by oral therapy for an additional 7 to 14 days. The choice of oral antibiotic regimen for completion of therapy depends on the pathogen:</p><p class="bulletIndent1"><span class="glyph">●</span>For septic arthritis due to methicillin-sensitive <em>S. aureus</em>, suitable choices include <a class="drug drug_general" data-topicid="9349" href="/d/drug information/9349.html" rel="external">dicloxacillin</a> (500 mg orally every six hours), flucloxacillin (500 mg orally every six hours), or <a class="drug drug_general" data-topicid="9231" href="/d/drug information/9231.html" rel="external">cephalexin</a> (500 mg orally every six hours). Patients who are allergic to penicillin can be treated with <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> (600 mg orally every eight hours).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For septic arthritis due to methicillin-resistant <em>S. aureus</em>, suitable choices include <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a>, <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> (or <a class="drug drug_general" data-topicid="9653" href="/d/drug information/9653.html" rel="external">minocycline</a>), <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a> (or <a class="drug drug_general" data-topicid="96001" href="/d/drug information/96001.html" rel="external">tedizolid</a>), and <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a> in combination with either <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> or <a class="drug drug_general" data-topicid="8648" href="/d/drug information/8648.html" rel="external">fusidic acid</a>  (<a class="graphic graphic_table graphicRef114503" href="/d/graphic/114503.html" rel="external">table 7</a>).</p><p></p><p>For patients with septic arthritis due to organisms that are susceptible to oral agents with high bioavailability (such as a fluoroquinolone), we favor treatment with a short course (four to seven days) of parenteral therapy, followed by 14 to 21 days of oral therapy. Compliance and response to therapy should be monitored carefully in such cases.</p><p>For patients with septic arthritis due to difficult-to-treat pathogens (such as <em>P. aeruginosa</em> or <em>Enterobacter</em> spp), longer courses of outpatient parenteral antibiotic therapy (eg, three to four weeks) may be necessary, especially if the response to therapy is slow or the patient is immunosuppressed.</p><p>For patients with septic arthritis and contiguous osteomyelitis, a long (four to six week) course of antibiotics may be indicated. (See  <a class="medical medical_review" href="/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment"</a>.)</p><p>For patients with septic arthritis in the setting of endocarditis, the duration of therapy is guided by the duration required for treatment of endocarditis. (See  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a>.)</p><p>One randomized trial suggested two weeks of antibiotic therapy may be noninferior to four weeks of therapy after surgical drainage; however, of the 154 patients enrolled, most had septic arthritis of the wrist or hand (64 percent); only 1 hip infection and 14 knee infections were included [<a href="#rid70">70</a>]. Furthermore, there no cases of infection due to methicillin-resistant <em>S. aureus</em>, and more than two-thirds of patients had pathogens other than <em>S. aureus</em>.</p><p class="headingAnchor" id="H22"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>In the United States, these were 13,700 hospital admissions for septic arthritis in 2012 [<a href="#rid2">2</a>]. Average length of stay was seven days and only 40 percent of patients were discharged home. Discharge to a rehabilitation or nursing facility, longer hospital stay, and worse outcome correlated with age &gt;50 years, Medicaid and self-pay as primary payer, teaching hospital status, heart failure, and diabetes. There was a 3 percent mortality rate during the primary hospitalization.</p><p>Unfortunately, there are few studies on the long-term joint outcome in patients with septic arthritis. In most, the functional outcome has depended on host factors (such as pre-existing joint disease), the virulence of the infecting organism, and duration of infection prior to initiation of therapy.</p><p>In one study including 121 adults with septic arthritis, a poor joint outcome (as defined by the need for amputation, arthrodesis, prosthetic surgery, or severe functional deterioration) occurred in one-third of the patients; adverse prognostic factors included older age and pre-existing joint disease [<a href="#rid9">9</a>].</p><p>The pathogen may also influence the outcome of treatment. In studies of septic arthritis due to <em>S. aureus, </em>poor joint outcomes have been observed in up to half of patients following completion of therapy [<a href="#rid11">11,71</a>]. In a three-year period, 93 patients with <em>S. aureus</em> arthritis were identified and 40 percent were methicillin-resistant <em>S. aureus</em> [<a href="#rid72">72</a>]. More than 90 percent of the cases were community acquired and 44 percent of the patients had diabetes mellitus. The in-hospital mortality rate was 5.4 percent. In contrast, a study of patients with pneumococcal septic arthritis noted a return to baseline joint function (or only mild limitation of joint motion) following therapy in 95 percent of cases [<a href="#rid29">29</a>].</p><p>Mortality due to septic arthritis depends on comorbid conditions such as advanced age, renal or cardiac disease, and immunosuppression. The mortality rates in most series range from 10 to 15 percent [<a href="#rid9">9</a>]. Polyarticular septic arthritis, particularly when it is due to <em>S. aureus</em> or occurs in the presence of rheumatoid arthritis, has an extremely poor prognosis, with mortality rates as high as 50 percent [<a href="#rid34">34</a>]. Mortality due to septic pneumococcal arthritis was reported as 19 percent in one series [<a href="#rid29">29</a>].</p><p>In a series of 55 patients treated with arthroscopic lavage and antibiotics for septic arthritis of the knee, medical comorbidities, increased age, and multiple medication use had worse outcomes [<a href="#rid73">73</a>].</p><p>The outcome of septic arthritis in people who inject drugs (PWID) is worse than in most other patient groups. In a nation-wide series of septic knees, the proportion of patients with injection drug user-related septic arthritis increased from 5 percent in 2000 to 11 percent in 2013 [<a href="#rid74">74</a>]. PWID-related cases were more likely to require repeat surgical procedures, longer hospital stays, and had higher mortality rates.</p><p>In one series including more than 500 adult cases of native joint septic arthritis in New Zealand between 2009 and 2014, large joint septic arthritis was associated with a higher rate of treatment failure than small joint septic arthritis (23 versus 12 percent) [<a href="#rid16">16</a>]. Adverse outcomes included death (5 percent), relapse (5 percent), reinfection (6 percent), and amputation (3 percent).</p><p class="headingAnchor" id="H383915514"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116712.html" rel="external">"Society guideline links: Septic arthritis in adults"</a>.)</p><p class="headingAnchor" id="H23"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83255.html" rel="external">"Patient education: Septic arthritis (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/517.html" rel="external">"Patient education: Arthritis (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/716.html" rel="external">"Patient education: Joint infection (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Septic arthritis refers to infection in a joint. Most commonly, septic arthritis arises via hematogenous seeding. It may also develop as a result of direct inoculation of bacteria into the joint. Rarely, septic arthritis develops via extension of infection into the joint space from adjacent tissues. (See <a class="local">'Introduction'</a> above and <a class="local">'Mechanism of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – Septic arthritis is usually monomicrobial. <em>Staphylococcus aureus</em> (including methicillin-resistant <em>S. aureus</em>) is the most common cause of septic arthritis in adults  (<a class="graphic graphic_table graphicRef57688" href="/d/graphic/57688.html" rel="external">table 1</a>). Other gram-positive organisms such as streptococci are also important potential causes. Septic arthritis due to gram-negative bacilli generally occurs in older adults, patients with underlying immunosuppression, or intravenous drug users; it may also occur as a complication of trauma. Rarely, nonbacterial organisms, such as fungi, can cause septic arthritis. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Patients with septic arthritis usually present acutely with a single swollen and painful joint (ie, monoarticular arthritis); oligoarticular or polyarticular infection occurs in approximately 20 percent of patients. Joint pain, swelling, warmth, and restricted movement occur in most cases. Patients with septic arthritis are usually febrile; older patients may be afebrile. The knee is involved in more than half of cases; wrists, ankles, and hips are also affected commonly. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to diagnosis</strong> – The diagnosis of septic arthritis should be suspected in patients with acute onset of at least one swollen, painful joint. Prior to administration of antibiotics, synovial fluid should be sent for Gram stain, bacterial culture, white blood cell count with differential, and assessment for crystals. In addition, blood cultures (two sets) and radiographs of the involved joint should be obtained. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interpreting diagnostic tests</strong> – The diagnosis of septic arthritis is established based on synovial fluid analysis and culture  (<a class="graphic graphic_algorithm graphicRef111452" href="/d/graphic/111452.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef76506" href="/d/graphic/76506.html" rel="external">table 2</a>). A definitive diagnosis is made if synovial fluid Gram stain and/or culture is positive. If synovial fluid Gram stain and culture are negative, a presumptive diagnosis can be made based on purulence of the synovial fluid (leukocyte count &gt;20,000 cells/microL, mostly neutrophils). (See <a class="local">'Diagnosis'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Treatment of acute bacterial arthritis consists of joint drainage or debridement coupled with antibiotic therapy. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Joint drainage or debridement</strong> – Approaches to joint drainage for management of septic arthritis include needle aspiration, arthroscopy, or arthrotomy (open surgical drainage). (See <a class="local">'Joint drainage'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Empiric antibiotic selection</strong> – The choice of empiric antimicrobial therapy should cover the most likely pathogens (see <a class="local">'Initial approach'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If the initial Gram stain of the synovial fluid shows gram-positive cocci, treatment consists of <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>  (<a class="graphic graphic_algorithm graphicRef134805" href="/d/graphic/134805.html" rel="external">algorithm 2</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If the initial Gram stain of the synovial fluid shows gram-negative bacilli, treatment should be guided by risk for Pseudomonal infection  (<a class="graphic graphic_algorithm graphicRef134805" href="/d/graphic/134805.html" rel="external">algorithm 2</a>). Patients with risk for <em>Pseudomonas</em> infection (eg, immunosuppressed patients and people who inject drugs [PWID]) warrant empiric coverage for <em>Pseudomonas</em> infection. </p><p></p><p class="bulletIndent3">For patients who have sepsis or septic shock, have neutropenia and bacteremia, have severe burns, or are in a setting where the incidence of resistance to the chosen antibiotic class is high (eg, &gt;10 to 15 percent), we suggest treatment a combination of two antipseudomonal agents from different antibiotic classes (eg, a beta-lactam with an aminoglycoside or a fluoroquinolone)  (<a class="graphic graphic_table graphicRef91115" href="/d/graphic/91115.html" rel="external">table 6</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See  <a class="medical medical_review" href="/d/html/3135.html" rel="external">"Principles of antimicrobial therapy of Pseudomonas aeruginosa infections"</a>.)</p><p></p><p class="bulletIndent3">For patients without any of these additional risk factors for mortality or resistant organisms, we suggest treatment with a single antipseudomonal agent  (<a class="graphic graphic_table graphicRef91115" href="/d/graphic/91115.html" rel="external">table 6</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). (See  <a class="medical medical_review" href="/d/html/3135.html" rel="external">"Principles of antimicrobial therapy of Pseudomonas aeruginosa infections"</a>.)</p><p></p><p class="bulletIndent3">For patients with no risk factors for <em>Pseudomonas</em> infection, treatment consists of a third-generation cephalosporin. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If the initial Gram stain of synovial fluid is negative but synovial fluid cell count is consistent with septic arthritis, the approach depends on individual clinical circumstances  (<a class="graphic graphic_algorithm graphicRef134806" href="/d/graphic/134806.html" rel="external">algorithm 3</a>). </p><p></p><p class="bulletIndent3">For immunocompetent patients without confounding factors (such as trauma), we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent3">For patients with traumatic bacterial arthritis, we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> plus a third-generation cephalosporin (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent3">For immunocompromised patients and PWID, we suggest treatment with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> plus a cephalosporin with activity again<em>st Pseudomonas</em> (<a class="drug drug_general" data-topicid="9226" href="/d/drug information/9226.html" rel="external">ceftazidime</a> or <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Targeted antibiotic therapy</strong> – Once microbiology and susceptibility data are available, antibiotic therapy should be narrowed. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Duration of therapy</strong> – The duration of therapy is tailored to individual clinical circumstances as described above. (See <a class="local">'Antibiotic therapy'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nair R, Schweizer ML, Singh N. Septic Arthritis and Prosthetic Joint Infections in Older Adults. Infect Dis Clin North Am 2017; 31:715.</a></li><li><a class="nounderline abstract_t">Singh JA, Yu S. Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends. Arthritis Care Res (Hoboken) 2018; 70:320.</a></li><li><a class="nounderline abstract_t">Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 2007; 297:1478.</a></li><li><a class="nounderline abstract_t">Mathews CJ, Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol 2008; 20:457.</a></li><li><a class="nounderline abstract_t">Borzio R, Mulchandani N, Pivec R, et al. Predictors of Septic Arthritis in the Adult Population. Orthopedics 2016; 39:e657.</a></li><li><a class="nounderline abstract_t">Carpenter CR, Schuur JD, Everett WW, Pines JM. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med 2011; 18:781.</a></li><li><a class="nounderline abstract_t">Gavet F, Tournadre A, Soubrier M, et al. Septic arthritis in patients aged 80 and older: a comparison with younger adults. J Am Geriatr Soc 2005; 53:1210.</a></li><li><a class="nounderline abstract_t">Elsissy JG, Liu JN, Wilton PJ, et al. Bacterial Septic Arthritis of the Adult Native Knee Joint: A Review. JBJS Rev 2020; 8:e0059.</a></li><li><a class="nounderline abstract_t">Kaandorp CJ, Krijnen P, Moens HJ, et al. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum 1997; 40:884.</a></li><li><a class="nounderline abstract_t">Goldenberg DL. Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin North Am 1991; 17:149.</a></li><li><a class="nounderline abstract_t">Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312:764.</a></li><li><a class="nounderline abstract_t">Mor A, Mitnick HJ, Greene JB, et al. Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. J Clin Rheumatol 2006; 12:87.</a></li><li><a class="nounderline abstract_t">Nadarajah K, Pritchard C. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis. J Clin Rheumatol 2005; 11:120.</a></li><li><a class="nounderline abstract_t">Schett G, Herak P, Graninger W, et al. Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature. J Clin Microbiol 2005; 43:2537.</a></li><li><a class="nounderline abstract_t">Katsarolis I, Tsiodras S, Panagopoulos P, et al. Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 2005; 37:304.</a></li><li><a class="nounderline abstract_t">McBride S, Mowbray J, Caughey W, et al. Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults. Clin Infect Dis 2020; 70:271.</a></li><li><a class="nounderline abstract_t">Gobao VC, Alfishawy M, Smith C, et al. Risk Factors, Screening, and Treatment Challenges in Staphylococcus aureus Native Septic Arthritis. Open Forum Infect Dis 2021; 8:ofaa593.</a></li><li><a class="nounderline abstract_t">Ross JJ, Ard KL, Carlile N. Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990-2018. Open Forum Infect Dis 2020; 7:ofaa089.</a></li><li><a class="nounderline abstract_t">Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 1996; 117:423.</a></li><li><a class="nounderline abstract_t">Mader JT, Shirtliff M, Calhoun JH. The host and the skeletal infection: classification and pathogenesis of acute bacterial bone and joint sepsis. Baillieres Best Pract Res Clin Rheumatol 1999; 13:1.</a></li><li><a class="nounderline abstract_t">Xu C, Peng H, Li R, et al. Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: A matched retrospective cohort analysis. Semin Arthritis Rheum 2018; 47:911.</a></li><li><a class="nounderline abstract_t">Balato G, Di Donato SL, Ascione T, et al. Knee Septic Arthritis after Arthroscopy: Incidence, Risk Factors, Functional Outcome, and Infection Eradication Rate. Joints 2017; 5:107.</a></li><li><a class="nounderline abstract_t">Mehr J, Ross K, Carothers B, et al. Outbreak of Bacterial Septic Arthritis Infections Associated with Intra-Articular Injections- New Jersey 2017. Am J Infect Control 2018; 46:S23.</a></li><li><a class="nounderline abstract_t">Aglas F, Gretler J, Rainer F, Krejs GJ. Sternoclavicular septic arthritis: a rare but serious complication of subclavian venous catheterization. Clin Rheumatol 1994; 13:507.</a></li><li><a class="nounderline abstract_t">Fromm SE, Toohey JS. Septic arthritis of the hip in an adult following repeated femoral venipuncture. Orthopedics 1996; 19:1047.</a></li><li><a class="nounderline abstract_t">Messieh M, Turner R, Bunch F, Camer S. Hip sepsis from retroperitoneal rupture of diverticular disease. Orthop Rev 1993; 22:597.</a></li><li><a class="nounderline abstract_t">Frazee BW, Fee C, Lambert L. How common is MRSA in adult septic arthritis? Ann Emerg Med 2009; 54:695.</a></li><li><a class="nounderline abstract_t">Nelson GE, Pondo T, Toews KA, et al. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. Clin Infect Dis 2016; 63:478.</a></li><li><a class="nounderline abstract_t">Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003; 36:319.</a></li><li><a class="nounderline abstract_t">Allison DC, Holtom PD, Patzakis MJ, Zalavras CG. Microbiology of bone and joint infections in injecting drug abusers. Clin Orthop Relat Res 2010; 468:2107.</a></li><li><a class="nounderline abstract_t">Mikhail IS, Alarcón GS. Nongonococcal bacterial arthritis. Rheum Dis Clin North Am 1993; 19:311.</a></li><li><a class="nounderline abstract_t">Ross JJ, Hu LT. Septic arthritis of the pubic symphysis: review of 100 cases. Medicine (Baltimore) 2003; 82:340.</a></li><li><a class="nounderline abstract_t">Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore) 2004; 83:139.</a></li><li><a class="nounderline abstract_t">Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine (Baltimore) 1993; 72:296.</a></li><li><a class="nounderline abstract_t">Sapico FL, Liquete JA, Sarma RJ. Bone and joint infections in patients with infective endocarditis: review of a 4-year experience. Clin Infect Dis 1996; 22:783.</a></li><li><a class="nounderline abstract_t">Hariharan P, Kabrhel C. Sensitivity of erythrocyte sedimentation rate and C-reactive protein for the exclusion of septic arthritis in emergency department patients. J Emerg Med 2011; 40:428.</a></li><li><a class="nounderline abstract_t">Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.</a></li><li><a class="nounderline abstract_t">Stirling P, Faroug R, Amanat S, et al. False-negative rate of gram-stain microscopy for diagnosis of septic arthritis: suggestions for improvement. Int J Microbiol 2014; 2014:830857.</a></li><li><a class="nounderline abstract_t">Kortekangas P, Aro HT, Lehtonen OP. Synovial fluid culture and blood culture in acute arthritis. A multi-case report of 90 patients. Scand J Rheumatol 1995; 24:44.</a></li><li><a class="nounderline abstract_t">Ike RW. Bacterial arthritis. Curr Opin Rheumatol 1998; 10:330.</a></li><li><a class="nounderline abstract_t">She RC, Romney MG, Jang W, et al. Performance of the BacT/Alert Virtuo Microbial Detection System for the culture of sterile body fluids: prospective multicentre study. Clin Microbiol Infect 2018; 24:992.</a></li><li><a class="nounderline abstract_t">Hughes JG, Vetter EA, Patel R, et al. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol 2001; 39:4468.</a></li><li><a class="nounderline abstract_t">Carter K, Doern C, Jo CH, Copley LA. The Clinical Usefulness of Polymerase Chain Reaction as a Supplemental Diagnostic Tool in the Evaluation and the Treatment of Children With Septic Arthritis. J Pediatr Orthop 2016; 36:167.</a></li><li><a class="nounderline abstract_t">Zhao J, Zhang S, Zhang L, et al. Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis. Am J Emerg Med 2017; 35:1166.</a></li><li><a class="nounderline abstract_t">Imagama T, Tokushige A, Seki K, et al. Early diagnosis of septic arthritis using synovial fluid presepsin: A preliminary study. J Infect Chemother 2019; 25:170.</a></li><li><a class="nounderline abstract_t">Saeed K, Dryden M, Sitjar A, White G. Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening. Infection 2013; 41:845.</a></li><li><a class="nounderline abstract_t">Tetreault MW, Wetters NG, Moric M, et al. Is synovial C-reactive protein a useful marker for periprosthetic joint infection? Clin Orthop Relat Res 2014; 472:3997.</a></li><li><a class="nounderline abstract_t">Shu E, Farshidpour L, Young M, et al. Utility of point-of-care synovial lactate to identify septic arthritis in the emergency department. Am J Emerg Med 2019; 37:502.</a></li><li><a class="nounderline abstract_t">Carpenter CR, Vandenberg J, Solomon M, et al. Diagnostic Accuracy of Synovial Lactate, Polymerase Chain Reaction, or Clinical Examination for Suspected Adult Septic Arthritis. J Emerg Med 2020; 59:339.</a></li><li><a class="nounderline abstract_t">Stirling P, Tahir M, Atkinson HD. The Limitations of Gram-stain Microscopy of Synovial Fluid in Concomitant Septic and Crystal Arthritis. Curr Rheumatol Rev 2018; 14:255.</a></li><li><a class="nounderline abstract_t">Goldenberg DL. Septic arthritis. Lancet 1998; 351:197.</a></li><li><a class="nounderline abstract_t">Massey PA, Clark MD, Walt JS, et al. Optimal Synovial Fluid Leukocyte Count Cutoff for Diagnosing Native Joint Septic Arthritis After Antibiotics: A Receiver Operating Characteristic Analysis of Accuracy. J Am Acad Orthop Surg 2021; 29:e1246.</a></li><li><a class="nounderline abstract_t">Palestro CJ. FDG-PET in musculoskeletal infections. Semin Nucl Med 2013; 43:367.</a></li><li><a class="nounderline abstract_t">Long B, Koyfman A, Gottlieb M. Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department. West J Emerg Med 2019; 20:331.</a></li><li><a class="nounderline abstract_t">Kohli R, Hadley S. Fungal arthritis and osteomyelitis. Infect Dis Clin North Am 2005; 19:831.</a></li><li><a class="nounderline abstract_t">Papanicolas LE, Hakendorf P, Gordon DL. Concomitant septic arthritis in crystal monoarthritis. J Rheumatol 2012; 39:157.</a></li><li><a class="nounderline abstract_t">Luo TD, Jarvis DL, Yancey HB, et al. Synovial Cell Count Poorly Predicts Septic Arthritis in the Presence of Crystalline Arthropathy. J Bone Jt Infect 2020; 5:118.</a></li><li><a class="nounderline abstract_t">Sharff KA, Richards EP, Townes JM. Clinical management of septic arthritis. Curr Rheumatol Rep 2013; 15:332.</a></li><li><a class="nounderline abstract_t">Thiery JA. Arthroscopic drainage in septic arthritides of the knee: a multicenter study. Arthroscopy 1989; 5:65.</a></li><li><a class="nounderline abstract_t">Stutz G, Kuster MS, Kleinstück F, Gächter A. Arthroscopic management of septic arthritis: stages of infection and results. Knee Surg Sports Traumatol Arthrosc 2000; 8:270.</a></li><li><a class="nounderline abstract_t">Sammer DM, Shin AY. Comparison of arthroscopic and open treatment of septic arthritis of the wrist. J Bone Joint Surg Am 2009; 91:1387.</a></li><li><a class="nounderline abstract_t">Johns BP, Loewenthal MR, Dewar DC. Open Compared with Arthroscopic Treatment of Acute Septic Arthritis of the Native Knee. J Bone Joint Surg Am 2017; 99:499.</a></li><li><a class="nounderline abstract_t">Mabille C, El Samad Y, Joseph C, et al. Medical versus surgical treatment in native hip and knee septic arthritis. Infect Dis Now 2021; 51:164.</a></li><li><a class="nounderline abstract_t">Hunter JG, Gross JM, Dahl JD, et al. Risk factors for failure of a single surgical debridement in adults with acute septic arthritis. J Bone Joint Surg Am 2015; 97:558.</a></li><li><a class="nounderline abstract_t">Ho G Jr. How best to drain an infected joint. Will we ever know for certain? J Rheumatol 1993; 20:2001.</a></li><li><a class="nounderline abstract_t">García-Arias M, Balsa A, Mola EM. Septic arthritis. Best Pract Res Clin Rheumatol 2011; 25:407.</a></li><li><a class="nounderline abstract_t">Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.</a></li><li><a class="nounderline abstract_t">Scarborough M, Li HK, Rombach I, et al. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technol Assess 2019; 23:1.</a></li><li><a class="nounderline abstract_t">Seidelman J, Sexton DJ. Is Long-term Oral Therapy for Treatment of Bone and Joint Infections Ready for Prime Time? Clin Infect Dis 2021; 73:e2589.</a></li><li><a class="nounderline abstract_t">Gjika E, Beaulieu JY, Vakalopoulos K, et al. Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial. Ann Rheum Dis 2019; 78:1114.</a></li><li><a class="nounderline abstract_t">Weston VC, Jones AC, Bradbury N, et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis 1999; 58:214.</a></li><li><a class="nounderline abstract_t">Lin WT, Wu CD, Cheng SC, et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus among Patients with Septic Arthritis Caused by Staphylococcus aureus. PLoS One 2015; 10:e0127150.</a></li><li><a class="nounderline abstract_t">Kang T, Lee JK. Host Factors Affect the Outcome of Arthroscopic Lavage Treatment of Septic Arthritis of the Knee. Orthopedics 2018; 41:e184.</a></li><li><a class="nounderline abstract_t">Oh DHW, Wurcel AG, Tybor DJ, et al. Increased Mortality and Reoperation Rates After Treatment for Septic Arthritis of the Knee in People Who Inject Drugs: Nationwide Inpatient Sample, 2000-2013. Clin Orthop Relat Res 2018; 476:1557.</a></li></ol></div><div id="topicVersionRevision">Topic 7666 Version 55.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29079156" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Septic Arthritis and Prosthetic Joint Infections in Older Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28464432" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17405973" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Does this adult patient have septic arthritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18525361" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Septic arthritis: current diagnostic and therapeutic algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27286047" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Predictors of Septic Arthritis in the Adult Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21843213" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Evidence-based diagnostics: adult septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16108940" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Septic arthritis in patients aged 80 and older: a comparison with younger adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31899698" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bacterial Septic Arthritis of the Adult Native Knee Joint: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9153550" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The outcome of bacterial arthritis: a prospective community-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2041884" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Septic arthritis and other infections of rheumatologic significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3883171" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bacterial arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16601543" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16357718" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15872306" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15804667" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Septic arthritis due to Salmonella enteritidis associated with infliximab use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30941403" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33511230" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Risk Factors, Screening, and Treatment Challenges in Staphylococcus aureus Native Septic Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32258206" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8972665" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : An 18 year clinical review of septic arthritis from tropical Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10952846" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The host and the skeletal infection: classification and pathogenesis of acute bacterial bone and joint sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29129326" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: A matched retrospective cohort analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29114639" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Knee Septic Arthritis after Arthroscopy: Incidence, Risk Factors, Functional Outcome, and Infection Eradication Rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Outbreak of Bacterial Septic Arthritis Infections Associated with Intra-Articular Injections- New Jersey 2017</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7835020" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sternoclavicular septic arthritis: a rare but serious complication of subclavian venous catheterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8972524" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Septic arthritis of the hip in an adult following repeated femoral venipuncture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8316423" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Hip sepsis from retroperitoneal rupture of diverticular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19665261" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : How common is MRSA in adult septic arthritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27105747" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12539074" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pneumococcal septic arthritis: review of 190 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20174899" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Microbiology of bone and joint infections in injecting drug abusers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8502774" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nongonococcal bacterial arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530783" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Septic arthritis of the pubic symphysis: review of 100 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15118542" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sternoclavicular septic arthritis: review of 180 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8412643" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Polyarticular septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8722931" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Bone and joint infections in patients with infective endocarditis: review of a 4-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20655163" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Sensitivity of erythrocyte sedimentation rate and C-reactive protein for the exclusion of septic arthritis in emergency department patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24678320" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : False-negative rate of gram-stain microscopy for diagnosis of septic arthritis: suggestions for improvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7863278" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Synovial fluid culture and blood culture in acute arthritis. A multi-case report of 90 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9725094" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Bacterial arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29274462" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Performance of the BacT/Alert Virtuo Microbial Detection System for the culture of sterile body fluids: prospective multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11724863" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25887824" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The Clinical Usefulness of Polymerase Chain Reaction as a Supplemental Diagnostic Tool in the Evaluation and the Treatment of Children With Septic Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28623003" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30473180" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Early diagnosis of septic arthritis using synovial fluid presepsin: A preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23645456" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25070920" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Is synovial C-reactive protein a useful marker for periprosthetic joint infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30593442" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Utility of point-of-care synovial lactate to identify septic arthritis in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32819785" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Diagnostic Accuracy of Synovial Lactate, Polymerase Chain Reaction, or Clinical Examination for Suspected Adult Septic Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28356052" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The Limitations of Gram-stain Microscopy of Synovial Fluid in Concomitant Septic and Crystal Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9449882" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33720058" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Optimal Synovial Fluid Leukocyte Count Cutoff for Diagnosing Native Joint Septic Arthritis After Antibiotics: A Receiver Operating Characteristic Analysis of Accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23905618" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : FDG-PET in musculoskeletal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30881554" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297735" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Fungal arthritis and osteomyelitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133623" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Concomitant septic arthritis in crystal monoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32566449" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Synovial Cell Count Poorly Predicts Septic Arthritis in the Presence of Crystalline Arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23591823" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical management of septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2650702" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Arthroscopic drainage in septic arthritides of the knee: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11061294" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Arthroscopic management of septic arthritis: stages of infection and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19487516" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Comparison of arthroscopic and open treatment of septic arthritis of the wrist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28291183" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Open Compared with Arthroscopic Treatment of Acute Septic Arthritis of the Native Knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32387296" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Medical versus surgical treatment in native hip and knee septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25834080" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Risk factors for failure of a single surgical debridement in adults with acute septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8014923" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : How best to drain an infected joint. Will we ever know for certain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22100289" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21208910" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31373271" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32926118" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Is Long-term Oral Therapy for Treatment of Bone and Joint Infections Ready for Prime Time?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30992295" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10364899" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25996145" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : High Prevalence of Methicillin-Resistant Staphylococcus aureus among Patients with Septic Arthritis Caused by Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29309715" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Host Factors Affect the Outcome of Arthroscopic Lavage Treatment of Septic Arthritis of the Knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29762153" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Increased Mortality and Reoperation Rates After Treatment for Septic Arthritis of the Knee in People Who Inject Drugs: Nationwide Inpatient Sample, 2000-2013.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
